Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.

NCT06539481 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-infectious Uveitis Affecting the Posterior Segment of the Eye

Interventions

DRUG: fluocinolone acetonide 190 micrograms

Sponsor

Alimera Sciences